- Home
- NTR vs BNTX Comparison
NTR vs BNTX Comparison
Compare NTR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTR
- BNTX
- Stock Information
- Founded
- NTR N/A
- BNTX 2008
- Country
- NTR Canada
- BNTX Germany
- Employees
- NTR N/A
- BNTX N/A
- Industry
- NTR Agricultural Chemicals
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTR Industrials
- BNTX Health Care
- Exchange
- NTR Nasdaq
- BNTX Nasdaq
- Market Cap
- NTR 22.4B
- BNTX 23.9B
- IPO Year
- NTR N/A
- BNTX 2019
- Fundamental
- Price
- NTR $45.90
- BNTX $102.14
- Analyst Decision
- NTR Buy
- BNTX Strong Buy
- Analyst Count
- NTR 15
- BNTX 13
- Target Price
- NTR $59.00
- BNTX $139.46
- AVG Volume (30 Days)
- NTR 2.2M
- BNTX 1.0M
- Earning Date
- NTR 11-06-2024
- BNTX 11-04-2024
- Dividend Yield
- NTR 4.74%
- BNTX N/A
- EPS Growth
- NTR N/A
- BNTX N/A
- EPS
- NTR 1.48
- BNTX N/A
- Revenue
- NTR $25,556,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- NTR N/A
- BNTX N/A
- Revenue Next Year
- NTR $2.71
- BNTX N/A
- P/E Ratio
- NTR $31.05
- BNTX N/A
- Revenue Growth
- NTR N/A
- BNTX N/A
- 52 Week Low
- NTR $44.65
- BNTX $76.53
- 52 Week High
- NTR $60.87
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- NTR 37.97
- BNTX 41.18
- Support Level
- NTR $47.66
- BNTX $94.31
- Resistance Level
- NTR $47.53
- BNTX $108.01
- Average True Range (ATR)
- NTR 1.22
- BNTX 5.67
- MACD
- NTR -0.35
- BNTX -0.75
- Stochastic Oscillator
- NTR 11.33
- BNTX 36.22
About NTR Nutrien Ltd.
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.